Data / Form D filings / TITAN PHARMACEUTICALS INC
TITAN PHARMACEUTICALS INC: Form D filings
TITAN PHARMACEUTICALS INC, a pharmaceuticals company in San Francisco, CA, filed 4 Form D notices with the SEC between 2019 and 2022. The latest, on February 7, 2022, reports $1.5 million sold of a $7 million offering to 1 investor.
Find out what TITAN PHARMACEUTICALS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 400 OYSTER POINT BLVD, SUITE 505, San Francisco, CA, 94080
- Phone
- (650) 244-4990
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 910267
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 7, 2022 | New notice | $7,019,570 | $1,520,669 | $5,498,901 | 1 | Feb 4, 2022 | sec.gov |
| Jan 21, 2021 | New notice | $9,673,750 | $9,673,750 | $0 | 7 | Jan 20, 2021 | sec.gov |
| Jan 9, 2020 | New notice | $2,175,000 | $2,175,000 | $0 | 5 | Jan 9, 2020 | sec.gov |
| Aug 19, 2019 | New notice | $2,125,512 | $2,125,512 | $0 | 1 | Aug 9, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Katherine Beebe DeVarney | Executive Officer, Director | |
| James R. McNab, Jr. | Director | |
| Marc Rubin | Executive Officer, Director | |
| Joseph A. Akers | Director | |
| M. David McFarlane | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Feb 7, 2022 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what TITAN PHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.